BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12898443)

  • 21. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
    Palefsky JM
    Semin Oncol; 2000 Aug; 27(4):471-9. PubMed ID: 10950374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
    J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations?
    Vernon SD; Icenogle JP; Johnson PR; Reeves WC
    Infect Agents Dis; 1992 Dec; 1(6):319-24. PubMed ID: 1344670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer in patients infected with the human immunodeficiency virus.
    Leitao MM; White P; Cracchiolo B
    Cancer; 2008 Jun; 112(12):2683-9. PubMed ID: 18438877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
    Ahdieh L; Klein RS; Burk R; Cu-Uvin S; Schuman P; Duerr A; Safaeian M; Astemborski J; Daniel R; Shah K
    J Infect Dis; 2001 Sep; 184(6):682-90. PubMed ID: 11517428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.
    Durante AJ; Williams AB; Da Costa M; Darragh TM; Khoshnood K; Palefsky JM
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):638-42. PubMed ID: 12869403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse.
    Drobacheff C; Dupont P; Mougin C; Bourezane Y; Challier B; Fantoli M; Bettinger D; Laurent R
    Eur J Dermatol; 2003; 13(4):367-71. PubMed ID: 12948917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
    Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
    J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project.
    Sirivongrangson P; Bollen LJ; Chaovavanich A; Suksripanich O; Virapat P; Tunthanathip P; Ausavapipit J; Lokpichat S; Siangphoe U; Jirarojwat N; Pobkeeree V; Supawitkul S; Tappero JW; Levine WC
    Sex Transm Dis; 2007 Feb; 34(2):104-7. PubMed ID: 16755274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
    Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
    Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers.
    Conti M; Agarossi A; Parazzini F; Muggiasca ML; Boschini A; Negri E; Casolati E
    Gynecol Oncol; 1993 Jun; 49(3):344-8. PubMed ID: 8390961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal anal cytology in high-risk human papilloma virus infection in HIV-infected Australians.
    Anderson J; Hoy J; Hillman R; Gittleson C; Hartel G; Medley G; Basser R
    Sex Transm Infect; 2008 Apr; 84(2):94-6. PubMed ID: 17881414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection.
    Spinillo A; Tenti P; Zappatore R; De Seta F; Silini E; Guaschino S
    Gynecol Oncol; 1993 Feb; 48(2):210-3. PubMed ID: 8381376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples.
    Mbulawa ZZ; Marais DJ; Johnson LF; Boulle A; Coetzee D; Williamson AL
    J Gen Virol; 2010 Dec; 91(Pt 12):3023-31. PubMed ID: 20719990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.